MOONLAKE IMMUNOTHERAPEUTICS
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company crating novel therapies, and unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients.
MOONLAKE IMMUNOTHERAPEUTICS
Social Links:
Industry:
Biotechnology
Address:
Zug, Zug, Switzerland
Country:
Switzerland
Website Url:
http://www.moonlaketx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
115 M USD
Stock Details
Investors List
Cormorant Asset Management
Cormorant Asset Management investment in Post-IPO Equity - MoonLake Immunotherapeutics
Ghost Tree Capital Group
Ghost Tree Capital Group investment in Post-IPO Equity - MoonLake Immunotherapeutics
BVF Partners
BVF Partners investment in Post-IPO Equity - MoonLake Immunotherapeutics
Surveyor Capital
Surveyor Capital investment in Post-IPO Equity - MoonLake Immunotherapeutics
RTW Investments LLC
RTW Investments LLC investment in Post-IPO Equity - MoonLake Immunotherapeutics
Tekla Capital Management
Tekla Capital Management investment in Post-IPO Equity - MoonLake Immunotherapeutics
653 Investment Partners
653 Investment Partners investment in Post-IPO Equity - MoonLake Immunotherapeutics
Asymmetry Capital Management
Asymmetry Capital Management investment in Post-IPO Equity - MoonLake Immunotherapeutics
Monashee Investment Management
Monashee Investment Management investment in Post-IPO Equity - MoonLake Immunotherapeutics
Official Site Inspections
http://www.moonlaketx.com Semrush global rank: 5.16 M Semrush visits lastest month: 1.57 K
- Host name: 185-151-30-126.ptr4.stackcp.net
- IP address: 185.151.30.126
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "MoonLake Immunotherapeutics"
Moonlake TX Immunotherapeutics
We are unlocking the value of Sonelokimab with our ambitious Phase 2 program across lead indications for hidradenitis suppurativa and psoriatic arthritis. MoonLake Immunotherapeutics …See details»
About Us | Moonlake TX Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients.See details»
Associate Director, Regulatory Affairs - MoonLake
Nov 13, 2024 · Job PurposeAs an Associate Director, Regulatory Affairs, you are an integral part of MoonLake’s team and will be responsible for developing and delivering innovative global …See details»
MoonLake Immunotherapeutics
Mar 11, 2024 · In this presentation, we rely on, and refer to, publicly available information and statistics regarding market participants in the sector in which we compete and other industry …See details»
MoonLake Immunotherapeutics signs development and …
Jul 26, 2022 · MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of sonelokimab, a novel investigational Nanobody ® for the treatment …See details»
MoonLake Immunotherapeutics - ir.moonlaketx.com
In this presentation, we rely on, and refer to, publicly available information and statistics regarding market participants in the sector in which we compete and other industry data. Any …See details»
MoonLake Immunotherapeutics (Group) - Life-Sciences-Europe.com
Jan 1, 2021 · MoonLake Immunotherapeutics AG, founded in 2021, is a clinical-stage biopharmaceutical company leveraging Nanobody® technology to develop next-level …See details»
MoonLake Immunotherapeutics - VentureRadar
Website: https://www.moonlaketx.com Develops next-level immunologic medicines using Nanobody® technology for inflammatory skin and joint diseases, potentially partnering with …See details»
Careers | Moonlake TX Immunotherapeutics
We continuously connect the science to the human elements of inflammatory disease which is inspiring as we resolve to transform treatment outcomes for patients. Our strong team culture, …See details»
MoonLake Immunotherapeutics Reports Third Quarter 2024 …
ZUG, Switzerland, November 7, 2024 – MoonLake Immunotherapeutics (NASDAQ:MLTX) (“MoonLake” or the “Company”), a clinical-stage biotechnology company focused on creating …See details»
MoonLake Immunotherapeutics AG – Swiss Biotech
Our validated platform uses intact patients tumors, maintains their complexity and cellular component, and overcomes organoids. This allows to reliably assess at the pre-clinical stage …See details»
MoonLake Immunotherapeutics - Overview, News & Similar
May 16, 2024 · View MoonLake Immunotherapeutics (www.moonlaketx.com) location in Zug, Switzerland , revenue, industry and description. Find related and similar companies as well as …See details»
INVESTOR RELATIONS - moonlaketx.gcs-web.com
Apr 10, 2024 · MoonLake Immunotherapeutics inks three-year technology partnership with Komodo Health to advance research on inflammatory skin and joint conditions. MoonLake to …See details»
MoonLake Immunotherapeutics (MLTX) - Stock Analysis
2 days ago · Get a real-time MoonLake Immunotherapeutics (MLTX) stock price quote with breaking news, financials, statistics, charts and more.See details»
MLTX Stock Price Quote | Morningstar
Nov 15, 2024 · See the latest MoonLake Immunotherapeutics Class A stock price (MLTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.See details»
Senior Manager, Regulatory Affairs - MoonLake
As a Senior Manager, Regulatory Affairs, you are an integral part of MoonLake’s team and will be responsible for developing and delivering innovative global regulatory strategies for …See details»
Events & Presentations - MoonLake Immunotherapeutics
MoonLake Immunotherapeutics AG Dorfstrasse 29, 6300 Zug, Schweiz/Switzerland e: [email protected] media: [email protected] IR: [email protected]See details»
MoonLake Immunotherapeutics achieves landmark milestone with …
ZUG, Switzerland, June 25, 2023 – MoonLake Immunotherapeutics (“MoonLake”; Nasdaq: MLTX), a clinical-stage biotechnology company focused on creating next-level therapies for …See details»
Privacy Policy Notice | Moonlake TX Immunotherapeutics
This Privacy Notice (hereinafter referred to as, “Notice”) contains general information on what personal data MoonLake Immunotherapeutics AG – https://www.moonlaketx.com (‘MoonLake‘ …See details»
Interleukin-17 Inhibitors in the Treatment of Hidradenitis …
19 hours ago · Hidradenitis suppurativa (HS) is a chronic, debilitating, inflammatory dermatosis that significantly impacts patients’ quality of life, primarily manifesting as inflammatory nodules, …See details»